There were trends for increased risk of T2D with predicted exposure to statins and inhibitors of PCSK9 and NPC1L1 (as has been observed previously31, 32), although results from NPC1L1 variants were estimated with limited precision. The gene discussed is NPC1L1; the disease is type 2 diabetes mellitus.